D. Marazziti - Volume 5, Settembre 1999, n.3
Testo Immagini Bibliografia Summary Riassunto Indice
Ruolo di un inibitore selettivo del
reuptake della noradrenalina, la reboxetina,
nella terapia della depressione
Role of a selective noradrenaline re-uptake
inhibitor, reboxetine
in the treatment of depression
1) Marazziti D, Calzeroni A, Sacchetti E.
Etiopatogenesi della depressione.
In: Trattato Italiano di Psichiatra. Milano: Masson Italia1999:1843-1858.
2) Foote SL, Aston-Jones GS.
Pharmacology and physiology of central noradrenergic system.
In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation
of Progress. New York: Raven Press 1995:335-345.
3) Barker EL, Blakely RD.
Norepinephrine and serotonin transporters. Molecular targets of antidepressant
drugs.
In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation
of Progress. New York: Raven Press 1995:321-333.
4) Leonard BE.
The role of noradrenaline in depression: a review.
Journal of Psychopharmacology 1997;11(Suppl. 4):39-47.
5) Mongeau R, Blier P, de Montigny C.
The serotoninergic and noradrenergic systems of the hippocampus: their
interactions and the effects of antidepressant treatments.
Brain Research Review 1997;23:145-195.
6) Brady LS.
Stress, antidepressant drugs and the locus coeruleus.
Brain Research Bulletin 1994;35:545-556.
7) Maas JW.
Biogenic amines and depression.
Archives of General Psychiatry 1975;32:1357-1361.
8) Schildkraut JJ, Draskoczy PR, Gerschon ES, Reich P, Grab EL.
Catecholamine metabolism in affective disorders. IV. Preliminary studies
of norepinephrine metabolism in depressed patients treated with amitriptyline.
Journal of Psychiatric Research 1972;9:173-185.
9) Leonard BE.
Noradrenaline in basic models of depression.
European Neuropsychopharmacology 1997;7(Suppl. 1):11-16.
10) Nutt DJ.
Noradrenaline in depression: half a century of progress.
Journal of Psychopharmacology 1997;11(Suppl. 4);3-9.
11) Dostert P, Benedetti MS, Poggesi I.
Review of the pharmacokinetics and metabolism of reboxetine, a selective
noradrenaline reuptake inhibitor.
European Neuropsychopharmacology 1997;7(Suppl. 1):23-35.
12) Duman RS, Nestler EJ.
Signal transduction in pathways for catecholamine receptors.
In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of
Progress. New York: Raven Press 1995:303-320.
13) Racagni G, Brunello N, Tinelli D, Perz J.
New biochemical hypotheses on the mechanism of action of antidepressant
drugs: cAMP-dependent phosphorylation system.
Pharmacopsychiatry 1992;25:51-55.
14) Nystrom C, Hallstrom T.
Double blind comparison between a serotonin and a noradrenaline reuptake
blocker in the treatment of depressed patients.
Acta Psychiatrica Scandinavica 1985;78:384-390.
15) Montgomery SA.
Is there a role for a pure noradrenergic drug in the treatment of depression?
European Neuropsychopharmacology 1997;(Suppl. 1):3-9.
16) Mucci M.
Reboxetine: a review of antidepressant tolerability.
Journal of Psychopharmacology 1997;11(Suppl.4): 33-37.
17) Hindmarch I.
The effects of antidepressants on psychomotor function with particular
reference to reboxetine.
European Neuropsychopharmacology 1997;7(Suppl. 1):17-21.
18) Healy D, Mc Monagle T.
The enhancement of social functioning as a therapeutic principle in the
management of depression.
Journal of Psychopharmacology 1997;11(Suppl. 4):25-31.
19) Dubini A, Bosc M, Polin V.
Noradrenaline-selective versus serotonin-selective antidepressant therapy:
differential effects on social functioning.
Journal of Psychopharmacology 1997;11(Suppl. 4):17-23.
20) Berzewski H, Van Moffaert M, Gagiano CA
Efficacy and tolerabity of reboxetine compared with imipramine in a double-blind
study in patients suffering from major depressive episodes.
European Neuropsychopharmacology 1997:7(Suppl. 1):37-47.
21) Montgomery SA, James D, Montgomery DB.
Pharmacological specifity is not the same thing as a clinical selectivity.
Journal of Psychopharmacology 1987;3:179-183.
22) Nemeroff CB, De Vane CL, Pollok B.
Newer antidepressant and the cytochrome P 450 system.
American Journal of Psychiatry 1996;153:311-320.
23) Park BK, Pirmohamed M, Kitteringham NR.
The role of the cytochrome P450 enzymes in hepatic and extrahepatic human
drug toxicity.
Pharmacology and Therapeutics 1995;68:385-424.
24) Sproule BA, Naranjo CA, Brenmer KE, Hassan PC.
Selective serotonin reuptake inhibitors and CNS drug interactions. A critical
review of the evidence.
Clinical Pharmacokinetics 1997;33:454-471.